Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Insulin use did not influence the higher risk for cardiovascular events after percutaneous coronary intervention compared with coronary artery bypass grafting in patients with diabetes and multivessel coronary disease, according to a secondary analysis of data from a 1,900-patient randomized trial.
The differences in clinical outcomes between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) with a drug-eluting stent were maintained regardless of the presence or absence of insulin treatment, Dr. George D. Dangas and his associates reported at the Transcatheter Cardiovascular Therapeutics annual meeting.
In the FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial, rates for the primary outcomes (a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke) were significantly higher in patients treated with PCI than in those treated with CABG ? 27% vs. 19% (N. Engl. J. Med. 2012;367:2375-84).
http://www.familypracticenews.com/n...insulin/f9562af878244cfb2b3fb570749c5a2d.html
The differences in clinical outcomes between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) with a drug-eluting stent were maintained regardless of the presence or absence of insulin treatment, Dr. George D. Dangas and his associates reported at the Transcatheter Cardiovascular Therapeutics annual meeting.
In the FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial, rates for the primary outcomes (a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke) were significantly higher in patients treated with PCI than in those treated with CABG ? 27% vs. 19% (N. Engl. J. Med. 2012;367:2375-84).
http://www.familypracticenews.com/n...insulin/f9562af878244cfb2b3fb570749c5a2d.html